Correlation Between Lobe Sciences and Mydecine Innovations

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lobe Sciences and Mydecine Innovations at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lobe Sciences and Mydecine Innovations into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lobe Sciences and Mydecine Innovations Group, you can compare the effects of market volatilities on Lobe Sciences and Mydecine Innovations and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lobe Sciences with a short position of Mydecine Innovations. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lobe Sciences and Mydecine Innovations.

Diversification Opportunities for Lobe Sciences and Mydecine Innovations

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between Lobe and Mydecine is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Lobe Sciences and Mydecine Innovations Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mydecine Innovations and Lobe Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lobe Sciences are associated (or correlated) with Mydecine Innovations. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mydecine Innovations has no effect on the direction of Lobe Sciences i.e., Lobe Sciences and Mydecine Innovations go up and down completely randomly.

Pair Corralation between Lobe Sciences and Mydecine Innovations

Assuming the 90 days horizon Lobe Sciences is expected to generate 7.89 times more return on investment than Mydecine Innovations. However, Lobe Sciences is 7.89 times more volatile than Mydecine Innovations Group. It trades about 0.27 of its potential returns per unit of risk. Mydecine Innovations Group is currently generating about 0.19 per unit of risk. If you would invest  1.29  in Lobe Sciences on August 25, 2024 and sell it today you would lose (0.04) from holding Lobe Sciences or give up 3.1% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Lobe Sciences  vs.  Mydecine Innovations Group

 Performance 
       Timeline  
Lobe Sciences 

Risk-Adjusted Performance

27 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Lobe Sciences are ranked lower than 27 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain technical and fundamental indicators, Lobe Sciences reported solid returns over the last few months and may actually be approaching a breakup point.
Mydecine Innovations 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Mydecine Innovations Group are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Mydecine Innovations reported solid returns over the last few months and may actually be approaching a breakup point.

Lobe Sciences and Mydecine Innovations Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lobe Sciences and Mydecine Innovations

The main advantage of trading using opposite Lobe Sciences and Mydecine Innovations positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lobe Sciences position performs unexpectedly, Mydecine Innovations can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mydecine Innovations will offset losses from the drop in Mydecine Innovations' long position.
The idea behind Lobe Sciences and Mydecine Innovations Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios